MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$2,950,877
Prepaid expenses and
other current assets
$1,100,214
Deferred offering costs
$27,248
Prepaid expenses, net of
current portion
$552,839
Property and equipment,
net
$22,014
Total current assets
$4,078,339
Total noncurrent
assets
$574,853
Total assets
$4,653,192
Total liabilities and
stockholders' equity
$4,653,192
Total liabilities
$4,582,487
Total stockholders'
equity
$70,705
Accumulated deficit
-$105,212,314
Total current
liabilities
$4,582,487
Additional paid-in capital
$105,282,208
Common stock, 0.001 par
value, 300,000,000...
$811
Accounts payable and
accrued expenses
$4,350,134
Notes payable
$232,353
Back
Back
Balance Sheet
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com